FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2276173742> ?p ?o ?g. }

• W2276173742 endingPage "810" @default.
• W2276173742 startingPage "803" @default.
• W2276173742 abstract "With the exception of the presence of the FIP1L1-PDGFRA fusion gene, little is known about predictors of imatinib response in clinically-defined hypereosinophilic syndrome (HES).Subjects with FIP1L1-PDGFRA-myeloid neoplasm (FP; n =12), PDGFRA-negative HES with ≥4 criteria suggestive of a myeloid neoplasm (MHES; n =10), or steroid-refractory PDGFRA-negative HES with <4 myeloid criteria (SR; n = 5) were enrolled in a prospective study of imatinib therapy (NCT00044304: registered at clinicaltrials.gov). The primary outcome was an eosinophil count <1.5 × 109/L at one month and improvement of clinical symptoms. Clinical, molecular, and bone marrow responses to imatinib were assessed. A retrospective cohort of 18 subjects with clinically-defined HES who received imatinib (300-400 mg daily ≥ 1 month) were classified according to the criteria used in the prospective study.Overall, imatinib response rates were 100% in the FP group (n = 16), 54% in the MHES group (n = 13) and 0% in the SR group (n = 16). The presence of ≥ 4 myeloid features was the sole predictor of response. After ≥ 18 months in complete remission, imatinib was tapered and discontinued in 8 FP and 1 MHES subjects. Seven subjects (6 FP, 1 MHES) remain in remission off therapy for a median of 29 months (range 14-36).Clinical features of MHES predict imatinib response in PDGFRA-negative HES." @default.
• W2276173742 created "2016-06-24" @default.
• W2276173742 creator A5005077693 @default.
• W2276173742 creator A5009738799 @default.
• W2276173742 creator A5016134316 @default.
• W2276173742 creator A5016157627 @default.
• W2276173742 creator A5021382264 @default.
• W2276173742 creator A5023161333 @default.
• W2276173742 creator A5058515045 @default.
• W2276173742 creator A5059237185 @default.
• W2276173742 creator A5061379753 @default.
• W2276173742 creator A5079704265 @default.
• W2276173742 date "2016-03-02" @default.
• W2276173742 modified "2023-10-04" @default.
• W2276173742 title "Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome" @default.
• W2276173742 cites W110944710 @default.
• W2276173742 cites W1574141134 @default.
• W2276173742 cites W1965231759 @default.
• W2276173742 cites W1971565434 @default.
• W2276173742 cites W1977436614 @default.
• W2276173742 cites W2012952884 @default.
• W2276173742 cites W2014316424 @default.
• W2276173742 cites W2019186253 @default.
• W2276173742 cites W2036180570 @default.
• W2276173742 cites W2036987278 @default.
• W2276173742 cites W2045528146 @default.
• W2276173742 cites W2045905423 @default.
• W2276173742 cites W2050068982 @default.
• W2276173742 cites W2064244980 @default.
• W2276173742 cites W2064367288 @default.
• W2276173742 cites W2064698668 @default.
• W2276173742 cites W2064797674 @default.
• W2276173742 cites W2068158468 @default.
• W2276173742 cites W2078398386 @default.
• W2276173742 cites W2083755767 @default.
• W2276173742 cites W2085402944 @default.
• W2276173742 cites W2121727047 @default.
• W2276173742 cites W2155591233 @default.
• W2276173742 cites W2171600077 @default.
• W2276173742 doi "https://doi.org/10.1111/all.12843" @default.
• W2276173742 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6109366" @default.
• W2276173742 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26797802" @default.
• W2276173742 hasPublicationYear "2016" @default.
• W2276173742 type Work @default.
• W2276173742 sameAs 2276173742 @default.
• W2276173742 citedByCount "42" @default.
• W2276173742 countsByYear W22761737422016 @default.
• W2276173742 countsByYear W22761737422017 @default.
• W2276173742 countsByYear W22761737422018 @default.
• W2276173742 countsByYear W22761737422019 @default.
• W2276173742 countsByYear W22761737422020 @default.
• W2276173742 countsByYear W22761737422021 @default.
• W2276173742 countsByYear W22761737422022 @default.
• W2276173742 countsByYear W22761737422023 @default.
• W2276173742 crossrefType "journal-article" @default.
• W2276173742 hasAuthorship W2276173742A5005077693 @default.
• W2276173742 hasAuthorship W2276173742A5009738799 @default.
• W2276173742 hasAuthorship W2276173742A5016134316 @default.
• W2276173742 hasAuthorship W2276173742A5016157627 @default.
• W2276173742 hasAuthorship W2276173742A5021382264 @default.
• W2276173742 hasAuthorship W2276173742A5023161333 @default.
• W2276173742 hasAuthorship W2276173742A5058515045 @default.
• W2276173742 hasAuthorship W2276173742A5059237185 @default.
• W2276173742 hasAuthorship W2276173742A5061379753 @default.
• W2276173742 hasAuthorship W2276173742A5079704265 @default.
• W2276173742 hasBestOaLocation W22761737422 @default.
• W2276173742 hasConcept C126322002 @default.
• W2276173742 hasConcept C143998085 @default.
• W2276173742 hasConcept C16930146 @default.
• W2276173742 hasConcept C188816634 @default.
• W2276173742 hasConcept C2775922572 @default.
• W2276173742 hasConcept C2777129736 @default.
• W2276173742 hasConcept C2777583451 @default.
• W2276173742 hasConcept C2777621362 @default.
• W2276173742 hasConcept C2778729363 @default.
• W2276173742 hasConcept C2780007613 @default.
• W2276173742 hasConcept C2780076729 @default.
• W2276173742 hasConcept C2781107747 @default.
• W2276173742 hasConcept C3019892230 @default.
• W2276173742 hasConcept C37307934 @default.
• W2276173742 hasConcept C71924100 @default.
• W2276173742 hasConcept C90924648 @default.
• W2276173742 hasConceptScore W2276173742C126322002 @default.
• W2276173742 hasConceptScore W2276173742C143998085 @default.
• W2276173742 hasConceptScore W2276173742C16930146 @default.
• W2276173742 hasConceptScore W2276173742C188816634 @default.
• W2276173742 hasConceptScore W2276173742C2775922572 @default.
• W2276173742 hasConceptScore W2276173742C2777129736 @default.
• W2276173742 hasConceptScore W2276173742C2777583451 @default.
• W2276173742 hasConceptScore W2276173742C2777621362 @default.
• W2276173742 hasConceptScore W2276173742C2778729363 @default.
• W2276173742 hasConceptScore W2276173742C2780007613 @default.
• W2276173742 hasConceptScore W2276173742C2780076729 @default.
• W2276173742 hasConceptScore W2276173742C2781107747 @default.
• W2276173742 hasConceptScore W2276173742C3019892230 @default.
• W2276173742 hasConceptScore W2276173742C37307934 @default.
• W2276173742 hasConceptScore W2276173742C71924100 @default.
• W2276173742 hasConceptScore W2276173742C90924648 @default.

• next